Literature DB >> 21711427

Non-alcoholic steatohepatitis-induced fibrosis: Toll-like receptors, reactive oxygen species and Jun N-terminal kinase.

David A Brenner1, Ekihiro Seki, Kojiro Taura, Tatiana Kisseleva, Samuele Deminicis, Keiko Iwaisako, Sayaka Inokuchi, Bernd Schnabl, Christopher H Oesterreicher, Yong H Paik, Kouichi Miura, Yuzo Kodama.   

Abstract

Non-alcoholic steatohepatitis (NASH) represents the progression of hepatic steatosis to streatohepatitis, fibrosis and cirrhosis. Three signaling pathways have been associated with this progression; Toll-like receptors, reactive oxygen species and Jun N-terminal kinase. This review will describe how activation of these three pathways is required for development of fibrosis in murine models of NASH. The three pathways are related and synergistic through intracellular cross-talk. Disruption of any of these pathways may inhibit NASH-induced fibrosis and are potential targets for therapeutic intervention.
© 2011 The Japan Society of Hepatology.

Entities:  

Year:  2011        PMID: 21711427      PMCID: PMC3341613          DOI: 10.1111/j.1872-034X.2011.00814.x

Source DB:  PubMed          Journal:  Hepatol Res        ISSN: 1386-6346            Impact factor:   4.288


  3 in total

1.  Toll-like receptor 9 promotes steatohepatitis by induction of interleukin-1beta in mice.

Authors:  Kouichi Miura; Yuzo Kodama; Sayaka Inokuchi; Bernd Schnabl; Tomonori Aoyama; Hirohide Ohnishi; Jerrold M Olefsky; David A Brenner; Ekihiro Seki
Journal:  Gastroenterology       Date:  2010-03-27       Impact factor: 22.682

2.  Role and cellular source of nicotinamide adenine dinucleotide phosphate oxidase in hepatic fibrosis.

Authors:  Samuele De Minicis; Ekihiro Seki; Yong-Han Paik; Christoph H Osterreicher; Yuzo Kodama; Johannes Kluwe; Luciano Torozzi; Katsumi Miyai; Antonio Benedetti; Robert F Schwabe; David A Brenner
Journal:  Hepatology       Date:  2010-10       Impact factor: 17.425

3.  c-Jun N-terminal kinase-1 from hematopoietic cells mediates progression from hepatic steatosis to steatohepatitis and fibrosis in mice.

Authors:  Yuzo Kodama; Tatiana Kisseleva; Keiko Iwaisako; Kouichi Miura; Kojiro Taura; Samuele De Minicis; Christoph H Osterreicher; Bernd Schnabl; Ekihiro Seki; David A Brenner
Journal:  Gastroenterology       Date:  2009-06-21       Impact factor: 22.682

  3 in total
  21 in total

Review 1.  Non-alcoholic fatty liver disease and diabetes: from physiopathological interplay to diagnosis and treatment.

Authors:  Nathalie C Leite; Cristiane A Villela-Nogueira; Claudia R L Cardoso; Gil F Salles
Journal:  World J Gastroenterol       Date:  2014-07-14       Impact factor: 5.742

Review 2.  Microbiota and nonalcoholic steatohepatitis.

Authors:  Kento Imajo; Masato Yoneda; Yuji Ogawa; Koichiro Wada; Atsushi Nakajima
Journal:  Semin Immunopathol       Date:  2013-12-14       Impact factor: 9.623

Review 3.  Animal Models Correlating Immune Cells for the Development of NAFLD/NASH.

Authors:  Srikanth Iyer; Pramod Kumar Upadhyay; Subeer S Majumdar; Perumal Nagarajan
Journal:  J Clin Exp Hepatol       Date:  2015-07-09

Review 4.  Bone marrow-derived fibrocytes contribute to liver fibrosis.

Authors:  Jun Xu; Tatiana Kisseleva
Journal:  Exp Biol Med (Maywood)       Date:  2015-05-12

Review 5.  Sterile inflammation in the liver and pancreas.

Authors:  Rafaz Hoque; Ahmad Farooq; Wajahat Z Mehal
Journal:  J Gastroenterol Hepatol       Date:  2013-08       Impact factor: 4.029

Review 6.  Genetically modified mouse models for the study of nonalcoholic fatty liver disease.

Authors:  Perumal Nagarajan; M Jerald Mahesh Kumar; Ramasamy Venkatesan; Subeer S Majundar; Ramesh C Juyal
Journal:  World J Gastroenterol       Date:  2012-03-21       Impact factor: 5.742

7.  Aging increases the susceptibility of hepatic inflammation, liver fibrosis and aging in response to high-fat diet in mice.

Authors:  In Hee Kim; Jun Xu; Xiao Liu; Yukinori Koyama; Hsiao-Yen Ma; Karin Diggle; Young-Hyun You; Jan M Schilling; Dilip Jeste; Kumar Sharma; David A Brenner; Tatiana Kisseleva
Journal:  Age (Dordr)       Date:  2016-08-30

8.  NLRP3 inflammasome driven liver injury and fibrosis: Roles of IL-17 and TNF in mice.

Authors:  Alexander Wree; Matthew D McGeough; Maria Eugenia Inzaugarat; Akiko Eguchi; Susanne Schuster; Casey D Johnson; Carla A Peña; Lukas J Geisler; Bettina G Papouchado; Hal M Hoffman; Ariel E Feldstein
Journal:  Hepatology       Date:  2017-12-28       Impact factor: 17.425

9.  Impact of dietary fat on the development of non-alcoholic fatty liver disease in Ldlr-/- mice.

Authors:  Donald B Jump; Christopher M Depner; Sasmita Tripathy; Kelli A Lytle
Journal:  Proc Nutr Soc       Date:  2015-08-18       Impact factor: 6.297

10.  Increased expression of c-Jun in nonalcoholic fatty liver disease.

Authors:  Christoph Dorn; Julia C Engelmann; Michael Saugspier; Andreas Koch; Arndt Hartmann; Martina Müller; Rainer Spang; Anja Bosserhoff; Claus Hellerbrand
Journal:  Lab Invest       Date:  2014-02-03       Impact factor: 5.662

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.